Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing.
Saved in:
| Title: | Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing. |
|---|---|
| Authors: | Mastorino, Luca1 (AUTHOR) lucamastorino02@gmail.com, Dapavo, Paolo1 (AUTHOR), Ortoncelli, Michela1 (AUTHOR), Bongiovanni, Eleonora1 (AUTHOR), Liao, Yingying1 (AUTHOR), Leo, Francesco1 (AUTHOR), Quaglino, Pietro1 (AUTHOR), Ribero, Simone1 (AUTHOR) |
| Source: | Experimental Dermatology. Feb2025, Vol. 34 Issue 2, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
